Global Alpha L-Iduronidase Market Insights, Forecast to 2028

Report ID: 1749700 | Published Date: Jan 2025 | No. of Page: 114 | Base Year: 2024 | Rating: 4.2 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Alpha L-Iduronidase Product Introduction
    1.2 Market by Type
        1.2.1 Global Alpha L-Iduronidase Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 IDUA
        1.2.3 EC 3.2.1.76
    1.3 Market by Application
        1.3.1 Global Alpha L-Iduronidase Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Oncology
        1.3.3 Dermatology
        1.3.4 Immunology
        1.3.5 Musculoskeletal Disorders
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global Alpha L-Iduronidase Sales Estimates and Forecasts 2017-2028
    2.2 Global Alpha L-Iduronidase Revenue Estimates and Forecasts 2017-2028
    2.3 Global Alpha L-Iduronidase Revenue by Region: 2017 VS 2021 VS 2028
    2.4 Global Alpha L-Iduronidase Sales by Region
        2.4.1 Global Alpha L-Iduronidase Sales by Region (2017-2022)
        2.4.2 Global Sales Alpha L-Iduronidase by Region (2023-2028)
    2.5 Global Alpha L-Iduronidase Revenue by Region
        2.5.1 Global Alpha L-Iduronidase Revenue by Region (2017-2022)
        2.5.2 Global Alpha L-Iduronidase Revenue by Region (2023-2028)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Alpha L-Iduronidase Sales by Manufacturers
        3.1.1 Global Top Alpha L-Iduronidase Manufacturers by Sales (2017-2022)
        3.1.2 Global Alpha L-Iduronidase Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Alpha L-Iduronidase in 2021
    3.2 Global Alpha L-Iduronidase Revenue by Manufacturers
        3.2.1 Global Alpha L-Iduronidase Revenue by Manufacturers (2017-2022)
        3.2.2 Global Alpha L-Iduronidase Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by Alpha L-Iduronidase Revenue in 2021
    3.3 Global Alpha L-Iduronidase Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Alpha L-Iduronidase Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Alpha L-Iduronidase Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global Alpha L-Iduronidase Sales by Type
        4.1.1 Global Alpha L-Iduronidase Historical Sales by Type (2017-2022)
        4.1.2 Global Alpha L-Iduronidase Forecasted Sales by Type (2023-2028)
        4.1.3 Global Alpha L-Iduronidase Sales Market Share by Type (2017-2028)
    4.2 Global Alpha L-Iduronidase Revenue by Type
        4.2.1 Global Alpha L-Iduronidase Historical Revenue by Type (2017-2022)
        4.2.2 Global Alpha L-Iduronidase Forecasted Revenue by Type (2023-2028)
        4.2.3 Global Alpha L-Iduronidase Revenue Market Share by Type (2017-2028)
    4.3 Global Alpha L-Iduronidase Price by Type
        4.3.1 Global Alpha L-Iduronidase Price by Type (2017-2022)
        4.3.2 Global Alpha L-Iduronidase Price Forecast by Type (2023-2028)
5 Market Size by Application
    5.1 Global Alpha L-Iduronidase Sales by Application
        5.1.1 Global Alpha L-Iduronidase Historical Sales by Application (2017-2022)
        5.1.2 Global Alpha L-Iduronidase Forecasted Sales by Application (2023-2028)
        5.1.3 Global Alpha L-Iduronidase Sales Market Share by Application (2017-2028)
    5.2 Global Alpha L-Iduronidase Revenue by Application
        5.2.1 Global Alpha L-Iduronidase Historical Revenue by Application (2017-2022)
        5.2.2 Global Alpha L-Iduronidase Forecasted Revenue by Application (2023-2028)
        5.2.3 Global Alpha L-Iduronidase Revenue Market Share by Application (2017-2028)
    5.3 Global Alpha L-Iduronidase Price by Application
        5.3.1 Global Alpha L-Iduronidase Price by Application (2017-2022)
        5.3.2 Global Alpha L-Iduronidase Price Forecast by Application (2023-2028)
6 North America
    6.1 North America Alpha L-Iduronidase Market Size by Type
        6.1.1 North America Alpha L-Iduronidase Sales by Type (2017-2028)
        6.1.2 North America Alpha L-Iduronidase Revenue by Type (2017-2028)
    6.2 North America Alpha L-Iduronidase Market Size by Application
        6.2.1 North America Alpha L-Iduronidase Sales by Application (2017-2028)
        6.2.2 North America Alpha L-Iduronidase Revenue by Application (2017-2028)
    6.3 North America Alpha L-Iduronidase Market Size by Country
        6.3.1 North America Alpha L-Iduronidase Sales by Country (2017-2028)
        6.3.2 North America Alpha L-Iduronidase Revenue by Country (2017-2028)
        6.3.3 United States
        6.3.4 Canada
7 Europe
    7.1 Europe Alpha L-Iduronidase Market Size by Type
        7.1.1 Europe Alpha L-Iduronidase Sales by Type (2017-2028)
        7.1.2 Europe Alpha L-Iduronidase Revenue by Type (2017-2028)
    7.2 Europe Alpha L-Iduronidase Market Size by Application
        7.2.1 Europe Alpha L-Iduronidase Sales by Application (2017-2028)
        7.2.2 Europe Alpha L-Iduronidase Revenue by Application (2017-2028)
    7.3 Europe Alpha L-Iduronidase Market Size by Country
        7.3.1 Europe Alpha L-Iduronidase Sales by Country (2017-2028)
        7.3.2 Europe Alpha L-Iduronidase Revenue by Country (2017-2028)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Alpha L-Iduronidase Market Size by Type
        8.1.1 Asia Pacific Alpha L-Iduronidase Sales by Type (2017-2028)
        8.1.2 Asia Pacific Alpha L-Iduronidase Revenue by Type (2017-2028)
    8.2 Asia Pacific Alpha L-Iduronidase Market Size by Application
        8.2.1 Asia Pacific Alpha L-Iduronidase Sales by Application (2017-2028)
        8.2.2 Asia Pacific Alpha L-Iduronidase Revenue by Application (2017-2028)
    8.3 Asia Pacific Alpha L-Iduronidase Market Size by Region
        8.3.1 Asia Pacific Alpha L-Iduronidase Sales by Region (2017-2028)
        8.3.2 Asia Pacific Alpha L-Iduronidase Revenue by Region (2017-2028)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 China Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
9 Latin America
    9.1 Latin America Alpha L-Iduronidase Market Size by Type
        9.1.1 Latin America Alpha L-Iduronidase Sales by Type (2017-2028)
        9.1.2 Latin America Alpha L-Iduronidase Revenue by Type (2017-2028)
    9.2 Latin America Alpha L-Iduronidase Market Size by Application
        9.2.1 Latin America Alpha L-Iduronidase Sales by Application (2017-2028)
        9.2.2 Latin America Alpha L-Iduronidase Revenue by Application (2017-2028)
    9.3 Latin America Alpha L-Iduronidase Market Size by Country
        9.3.1 Latin America Alpha L-Iduronidase Sales by Country (2017-2028)
        9.3.2 Latin America Alpha L-Iduronidase Revenue by Country (2017-2028)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa Alpha L-Iduronidase Market Size by Type
        10.1.1 Middle East and Africa Alpha L-Iduronidase Sales by Type (2017-2028)
        10.1.2 Middle East and Africa Alpha L-Iduronidase Revenue by Type (2017-2028)
    10.2 Middle East and Africa Alpha L-Iduronidase Market Size by Application
        10.2.1 Middle East and Africa Alpha L-Iduronidase Sales by Application (2017-2028)
        10.2.2 Middle East and Africa Alpha L-Iduronidase Revenue by Application (2017-2028)
    10.3 Middle East and Africa Alpha L-Iduronidase Market Size by Country
        10.3.1 Middle East and Africa Alpha L-Iduronidase Sales by Country (2017-2028)
        10.3.2 Middle East and Africa Alpha L-Iduronidase Revenue by Country (2017-2028)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 ArmaGen Inc
        11.1.1 ArmaGen Inc Corporation Information
        11.1.2 ArmaGen Inc Overview
        11.1.3 ArmaGen Inc Alpha L-Iduronidase Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 ArmaGen Inc Alpha L-Iduronidase Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 ArmaGen Inc Recent Developments
    11.2 BioStrategies LC
        11.2.1 BioStrategies LC Corporation Information
        11.2.2 BioStrategies LC Overview
        11.2.3 BioStrategies LC Alpha L-Iduronidase Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 BioStrategies LC Alpha L-Iduronidase Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 BioStrategies LC Recent Developments
    11.3 Denali Therapeutics Inc
        11.3.1 Denali Therapeutics Inc Corporation Information
        11.3.2 Denali Therapeutics Inc Overview
        11.3.3 Denali Therapeutics Inc Alpha L-Iduronidase Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 Denali Therapeutics Inc Alpha L-Iduronidase Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 Denali Therapeutics Inc Recent Developments
    11.4 EdiGene Inc
        11.4.1 EdiGene Inc Corporation Information
        11.4.2 EdiGene Inc Overview
        11.4.3 EdiGene Inc Alpha L-Iduronidase Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 EdiGene Inc Alpha L-Iduronidase Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 EdiGene Inc Recent Developments
    11.5 Gain Therapeutics Inc
        11.5.1 Gain Therapeutics Inc Corporation Information
        11.5.2 Gain Therapeutics Inc Overview
        11.5.3 Gain Therapeutics Inc Alpha L-Iduronidase Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 Gain Therapeutics Inc Alpha L-Iduronidase Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 Gain Therapeutics Inc Recent Developments
    11.6 Immusoft Corp
        11.6.1 Immusoft Corp Corporation Information
        11.6.2 Immusoft Corp Overview
        11.6.3 Immusoft Corp Alpha L-Iduronidase Sales, Price, Revenue and Gross Margin (2017-2022)
        11.6.4 Immusoft Corp Alpha L-Iduronidase Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 Immusoft Corp Recent Developments
    11.7 JCR Pharmaceuticals Co Ltd
        11.7.1 JCR Pharmaceuticals Co Ltd Corporation Information
        11.7.2 JCR Pharmaceuticals Co Ltd Overview
        11.7.3 JCR Pharmaceuticals Co Ltd Alpha L-Iduronidase Sales, Price, Revenue and Gross Margin (2017-2022)
        11.7.4 JCR Pharmaceuticals Co Ltd Alpha L-Iduronidase Product Model Numbers, Pictures, Descriptions and Specifications
        11.7.5 JCR Pharmaceuticals Co Ltd Recent Developments
    11.8 Orchard Therapeutics Plc
        11.8.1 Orchard Therapeutics Plc Corporation Information
        11.8.2 Orchard Therapeutics Plc Overview
        11.8.3 Orchard Therapeutics Plc Alpha L-Iduronidase Sales, Price, Revenue and Gross Margin (2017-2022)
        11.8.4 Orchard Therapeutics Plc Alpha L-Iduronidase Product Model Numbers, Pictures, Descriptions and Specifications
        11.8.5 Orchard Therapeutics Plc Recent Developments
    11.9 Ossianix Inc
        11.9.1 Ossianix Inc Corporation Information
        11.9.2 Ossianix Inc Overview
        11.9.3 Ossianix Inc Alpha L-Iduronidase Sales, Price, Revenue and Gross Margin (2017-2022)
        11.9.4 Ossianix Inc Alpha L-Iduronidase Product Model Numbers, Pictures, Descriptions and Specifications
        11.9.5 Ossianix Inc Recent Developments
    11.10 Rain Bio Inc
        11.10.1 Rain Bio Inc Corporation Information
        11.10.2 Rain Bio Inc Overview
        11.10.3 Rain Bio Inc Alpha L-Iduronidase Sales, Price, Revenue and Gross Margin (2017-2022)
        11.10.4 Rain Bio Inc Alpha L-Iduronidase Product Model Numbers, Pictures, Descriptions and Specifications
        11.10.5 Rain Bio Inc Recent Developments
    11.11 RegenxBio Inc
        11.11.1 RegenxBio Inc Corporation Information
        11.11.2 RegenxBio Inc Overview
        11.11.3 RegenxBio Inc Alpha L-Iduronidase Sales, Price, Revenue and Gross Margin (2017-2022)
        11.11.4 RegenxBio Inc Alpha L-Iduronidase Product Model Numbers, Pictures, Descriptions and Specifications
        11.11.5 RegenxBio Inc Recent Developments
    11.12 Tega Therapeutics Inc
        11.12.1 Tega Therapeutics Inc Corporation Information
        11.12.2 Tega Therapeutics Inc Overview
        11.12.3 Tega Therapeutics Inc Alpha L-Iduronidase Sales, Price, Revenue and Gross Margin (2017-2022)
        11.12.4 Tega Therapeutics Inc Alpha L-Iduronidase Product Model Numbers, Pictures, Descriptions and Specifications
        11.12.5 Tega Therapeutics Inc Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 Alpha L-Iduronidase Industry Chain Analysis
    12.2 Alpha L-Iduronidase Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Alpha L-Iduronidase Production Mode & Process
    12.4 Alpha L-Iduronidase Sales and Marketing
        12.4.1 Alpha L-Iduronidase Sales Channels
        12.4.2 Alpha L-Iduronidase Distributors
    12.5 Alpha L-Iduronidase Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Alpha L-Iduronidase Industry Trends
    13.2 Alpha L-Iduronidase Market Drivers
    13.3 Alpha L-Iduronidase Market Challenges
    13.4 Alpha L-Iduronidase Market Restraints
14 Key Findings in The Global Alpha L-Iduronidase Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer

List of Tables
    Table 1. Global Alpha L-Iduronidase Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of IDUA
    Table 3. Major Manufacturers of EC 3.2.1.76
    Table 4. Global Alpha L-Iduronidase Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 5. Global Alpha L-Iduronidase Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 6. Global Alpha L-Iduronidase Sales by Region (2017-2022) & (K Units)
    Table 7. Global Alpha L-Iduronidase Sales Market Share by Region (2017-2022)
    Table 8. Global Alpha L-Iduronidase Sales by Region (2023-2028) & (K Units)
    Table 9. Global Alpha L-Iduronidase Sales Market Share by Region (2023-2028)
    Table 10. Global Alpha L-Iduronidase Revenue by Region (2017-2022) & (US$ Million)
    Table 11. Global Alpha L-Iduronidase Revenue Market Share by Region (2017-2022)
    Table 12. Global Alpha L-Iduronidase Revenue by Region (2023-2028) & (US$ Million)
    Table 13. Global Alpha L-Iduronidase Revenue Market Share by Region (2023-2028)
    Table 14. Global Alpha L-Iduronidase Sales by Manufacturers (2017-2022) & (K Units)
    Table 15. Global Alpha L-Iduronidase Sales Share by Manufacturers (2017-2022)
    Table 16. Global Alpha L-Iduronidase Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 17. Global Alpha L-Iduronidase Revenue Share by Manufacturers (2017-2022)
    Table 18. Alpha L-Iduronidase Price by Manufacturers (2017-2022) &(US$/Unit)
    Table 19. Global Alpha L-Iduronidase Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 20. Global Alpha L-Iduronidase by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Alpha L-Iduronidase as of 2021)
    Table 21. Alpha L-Iduronidase Manufacturing Base Distribution and Headquarters
    Table 22. Manufacturers Alpha L-Iduronidase Product Offered
    Table 23. Date of Manufacturers Enter into Alpha L-Iduronidase Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Alpha L-Iduronidase Sales by Type (2017-2022) & (K Units)
    Table 26. Global Alpha L-Iduronidase Sales by Type (2023-2028) & (K Units)
    Table 27. Global Alpha L-Iduronidase Sales Share by Type (2017-2022)
    Table 28. Global Alpha L-Iduronidase Sales Share by Type (2023-2028)
    Table 29. Global Alpha L-Iduronidase Revenue by Type (2017-2022) & (US$ Million)
    Table 30. Global Alpha L-Iduronidase Revenue by Type (2023-2028) & (US$ Million)
    Table 31. Global Alpha L-Iduronidase Revenue Share by Type (2017-2022)
    Table 32. Global Alpha L-Iduronidase Revenue Share by Type (2023-2028)
    Table 33. Alpha L-Iduronidase Price by Type (2017-2022) & (US$/Unit)
    Table 34. Global Alpha L-Iduronidase Price Forecast by Type (2023-2028) & (US$/Unit)
    Table 35. Global Alpha L-Iduronidase Sales by Application (2017-2022) & (K Units)
    Table 36. Global Alpha L-Iduronidase Sales by Application (2023-2028) & (K Units)
    Table 37. Global Alpha L-Iduronidase Sales Share by Application (2017-2022)
    Table 38. Global Alpha L-Iduronidase Sales Share by Application (2023-2028)
    Table 39. Global Alpha L-Iduronidase Revenue by Application (2017-2022) & (US$ Million)
    Table 40. Global Alpha L-Iduronidase Revenue by Application (2023-2028) & (US$ Million)
    Table 41. Global Alpha L-Iduronidase Revenue Share by Application (2017-2022)
    Table 42. Global Alpha L-Iduronidase Revenue Share by Application (2023-2028)
    Table 43. Alpha L-Iduronidase Price by Application (2017-2022) & (US$/Unit)
    Table 44. Global Alpha L-Iduronidase Price Forecast by Application (2023-2028) & (US$/Unit)
    Table 45. North America Alpha L-Iduronidase Sales by Type (2017-2022) & (K Units)
    Table 46. North America Alpha L-Iduronidase Sales by Type (2023-2028) & (K Units)
    Table 47. North America Alpha L-Iduronidase Revenue by Type (2017-2022) & (US$ Million)
    Table 48. North America Alpha L-Iduronidase Revenue by Type (2023-2028) & (US$ Million)
    Table 49. North America Alpha L-Iduronidase Sales by Application (2017-2022) & (K Units)
    Table 50. North America Alpha L-Iduronidase Sales by Application (2023-2028) & (K Units)
    Table 51. North America Alpha L-Iduronidase Revenue by Application (2017-2022) & (US$ Million)
    Table 52. North America Alpha L-Iduronidase Revenue by Application (2023-2028) & (US$ Million)
    Table 53. North America Alpha L-Iduronidase Sales by Country (2017-2022) & (K Units)
    Table 54. North America Alpha L-Iduronidase Sales by Country (2023-2028) & (K Units)
    Table 55. North America Alpha L-Iduronidase Revenue by Country (2017-2022) & (US$ Million)
    Table 56. North America Alpha L-Iduronidase Revenue by Country (2023-2028) & (US$ Million)
    Table 57. Europe Alpha L-Iduronidase Sales by Type (2017-2022) & (K Units)
    Table 58. Europe Alpha L-Iduronidase Sales by Type (2023-2028) & (K Units)
    Table 59. Europe Alpha L-Iduronidase Revenue by Type (2017-2022) & (US$ Million)
    Table 60. Europe Alpha L-Iduronidase Revenue by Type (2023-2028) & (US$ Million)
    Table 61. Europe Alpha L-Iduronidase Sales by Application (2017-2022) & (K Units)
    Table 62. Europe Alpha L-Iduronidase Sales by Application (2023-2028) & (K Units)
    Table 63. Europe Alpha L-Iduronidase Revenue by Application (2017-2022) & (US$ Million)
    Table 64. Europe Alpha L-Iduronidase Revenue by Application (2023-2028) & (US$ Million)
    Table 65. Europe Alpha L-Iduronidase Sales by Country (2017-2022) & (K Units)
    Table 66. Europe Alpha L-Iduronidase Sales by Country (2023-2028) & (K Units)
    Table 67. Europe Alpha L-Iduronidase Revenue by Country (2017-2022) & (US$ Million)
    Table 68. Europe Alpha L-Iduronidase Revenue by Country (2023-2028) & (US$ Million)
    Table 69. Asia Pacific Alpha L-Iduronidase Sales by Type (2017-2022) & (K Units)
    Table 70. Asia Pacific Alpha L-Iduronidase Sales by Type (2023-2028) & (K Units)
    Table 71. Asia Pacific Alpha L-Iduronidase Revenue by Type (2017-2022) & (US$ Million)
    Table 72. Asia Pacific Alpha L-Iduronidase Revenue by Type (2023-2028) & (US$ Million)
    Table 73. Asia Pacific Alpha L-Iduronidase Sales by Application (2017-2022) & (K Units)
    Table 74. Asia Pacific Alpha L-Iduronidase Sales by Application (2023-2028) & (K Units)
    Table 75. Asia Pacific Alpha L-Iduronidase Revenue by Application (2017-2022) & (US$ Million)
    Table 76. Asia Pacific Alpha L-Iduronidase Revenue by Application (2023-2028) & (US$ Million)
    Table 77. Asia Pacific Alpha L-Iduronidase Sales by Region (2017-2022) & (K Units)
    Table 78. Asia Pacific Alpha L-Iduronidase Sales by Region (2023-2028) & (K Units)
    Table 79. Asia Pacific Alpha L-Iduronidase Revenue by Region (2017-2022) & (US$ Million)
    Table 80. Asia Pacific Alpha L-Iduronidase Revenue by Region (2023-2028) & (US$ Million)
    Table 81. Latin America Alpha L-Iduronidase Sales by Type (2017-2022) & (K Units)
    Table 82. Latin America Alpha L-Iduronidase Sales by Type (2023-2028) & (K Units)
    Table 83. Latin America Alpha L-Iduronidase Revenue by Type (2017-2022) & (US$ Million)
    Table 84. Latin America Alpha L-Iduronidase Revenue by Type (2023-2028) & (US$ Million)
    Table 85. Latin America Alpha L-Iduronidase Sales by Application (2017-2022) & (K Units)
    Table 86. Latin America Alpha L-Iduronidase Sales by Application (2023-2028) & (K Units)
    Table 87. Latin America Alpha L-Iduronidase Revenue by Application (2017-2022) & (US$ Million)
    Table 88. Latin America Alpha L-Iduronidase Revenue by Application (2023-2028) & (US$ Million)
    Table 89. Latin America Alpha L-Iduronidase Sales by Country (2017-2022) & (K Units)
    Table 90. Latin America Alpha L-Iduronidase Sales by Country (2023-2028) & (K Units)
    Table 91. Latin America Alpha L-Iduronidase Revenue by Country (2017-2022) & (US$ Million)
    Table 92. Latin America Alpha L-Iduronidase Revenue by Country (2023-2028) & (US$ Million)
    Table 93. Middle East and Africa Alpha L-Iduronidase Sales by Type (2017-2022) & (K Units)
    Table 94. Middle East and Africa Alpha L-Iduronidase Sales by Type (2023-2028) & (K Units)
    Table 95. Middle East and Africa Alpha L-Iduronidase Revenue by Type (2017-2022) & (US$ Million)
    Table 96. Middle East and Africa Alpha L-Iduronidase Revenue by Type (2023-2028) & (US$ Million)
    Table 97. Middle East and Africa Alpha L-Iduronidase Sales by Application (2017-2022) & (K Units)
    Table 98. Middle East and Africa Alpha L-Iduronidase Sales by Application (2023-2028) & (K Units)
    Table 99. Middle East and Africa Alpha L-Iduronidase Revenue by Application (2017-2022) & (US$ Million)
    Table 100. Middle East and Africa Alpha L-Iduronidase Revenue by Application (2023-2028) & (US$ Million)
    Table 101. Middle East and Africa Alpha L-Iduronidase Sales by Country (2017-2022) & (K Units)
    Table 102. Middle East and Africa Alpha L-Iduronidase Sales by Country (2023-2028) & (K Units)
    Table 103. Middle East and Africa Alpha L-Iduronidase Revenue by Country (2017-2022) & (US$ Million)
    Table 104. Middle East and Africa Alpha L-Iduronidase Revenue by Country (2023-2028) & (US$ Million)
    Table 105. ArmaGen Inc Corporation Information
    Table 106. ArmaGen Inc Description and Major Businesses
    Table 107. ArmaGen Inc Alpha L-Iduronidase Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 108. ArmaGen Inc Alpha L-Iduronidase Product Model Numbers, Pictures, Descriptions and Specifications
    Table 109. ArmaGen Inc Recent Developments
    Table 110. BioStrategies LC Corporation Information
    Table 111. BioStrategies LC Description and Major Businesses
    Table 112. BioStrategies LC Alpha L-Iduronidase Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 113. BioStrategies LC Alpha L-Iduronidase Product Model Numbers, Pictures, Descriptions and Specifications
    Table 114. BioStrategies LC Recent Developments
    Table 115. Denali Therapeutics Inc Corporation Information
    Table 116. Denali Therapeutics Inc Description and Major Businesses
    Table 117. Denali Therapeutics Inc Alpha L-Iduronidase Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 118. Denali Therapeutics Inc Alpha L-Iduronidase Product Model Numbers, Pictures, Descriptions and Specifications
    Table 119. Denali Therapeutics Inc Recent Developments
    Table 120. EdiGene Inc Corporation Information
    Table 121. EdiGene Inc Description and Major Businesses
    Table 122. EdiGene Inc Alpha L-Iduronidase Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 123. EdiGene Inc Alpha L-Iduronidase Product Model Numbers, Pictures, Descriptions and Specifications
    Table 124. EdiGene Inc Recent Developments
    Table 125. Gain Therapeutics Inc Corporation Information
    Table 126. Gain Therapeutics Inc Description and Major Businesses
    Table 127. Gain Therapeutics Inc Alpha L-Iduronidase Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 128. Gain Therapeutics Inc Alpha L-Iduronidase Product Model Numbers, Pictures, Descriptions and Specifications
    Table 129. Gain Therapeutics Inc Recent Developments
    Table 130. Immusoft Corp Corporation Information
    Table 131. Immusoft Corp Description and Major Businesses
    Table 132. Immusoft Corp Alpha L-Iduronidase Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 133. Immusoft Corp Alpha L-Iduronidase Product Model Numbers, Pictures, Descriptions and Specifications
    Table 134. Immusoft Corp Recent Developments
    Table 135. JCR Pharmaceuticals Co Ltd Corporation Information
    Table 136. JCR Pharmaceuticals Co Ltd Description and Major Businesses
    Table 137. JCR Pharmaceuticals Co Ltd Alpha L-Iduronidase Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 138. JCR Pharmaceuticals Co Ltd Alpha L-Iduronidase Product Model Numbers, Pictures, Descriptions and Specifications
    Table 139. JCR Pharmaceuticals Co Ltd Recent Developments
    Table 140. Orchard Therapeutics Plc Corporation Information
    Table 141. Orchard Therapeutics Plc Description and Major Businesses
    Table 142. Orchard Therapeutics Plc Alpha L-Iduronidase Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 143. Orchard Therapeutics Plc Alpha L-Iduronidase Product Model Numbers, Pictures, Descriptions and Specifications
    Table 144. Orchard Therapeutics Plc Recent Developments
    Table 145. Ossianix Inc Corporation Information
    Table 146. Ossianix Inc Description and Major Businesses
    Table 147. Ossianix Inc Alpha L-Iduronidase Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 148. Ossianix Inc Alpha L-Iduronidase Product Model Numbers, Pictures, Descriptions and Specifications
    Table 149. Ossianix Inc Recent Developments
    Table 150. Rain Bio Inc Corporation Information
    Table 151. Rain Bio Inc Description and Major Businesses
    Table 152. Rain Bio Inc Alpha L-Iduronidase Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 153. Rain Bio Inc Alpha L-Iduronidase Product Model Numbers, Pictures, Descriptions and Specifications
    Table 154. Rain Bio Inc Recent Developments
    Table 155. RegenxBio Inc Corporation Information
    Table 156. RegenxBio Inc Description and Major Businesses
    Table 157. RegenxBio Inc Alpha L-Iduronidase Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 158. RegenxBio Inc Alpha L-Iduronidase Product Model Numbers, Pictures, Descriptions and Specifications
    Table 159. RegenxBio Inc Recent Developments
    Table 160. Tega Therapeutics Inc Corporation Information
    Table 161. Tega Therapeutics Inc Description and Major Businesses
    Table 162. Tega Therapeutics Inc Alpha L-Iduronidase Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 163. Tega Therapeutics Inc Alpha L-Iduronidase Product Model Numbers, Pictures, Descriptions and Specifications
    Table 164. Tega Therapeutics Inc Recent Developments
    Table 165. Key Raw Materials Lists
    Table 166. Raw Materials Key Suppliers Lists
    Table 167. Alpha L-Iduronidase Distributors List
    Table 168. Alpha L-Iduronidase Customers List
    Table 169. Alpha L-Iduronidase Market Trends
    Table 170. Alpha L-Iduronidase Market Drivers
    Table 171. Alpha L-Iduronidase Market Challenges
    Table 172. Alpha L-Iduronidase Market Restraints
    Table 173. Research Programs/Design for This Report
    Table 174. Key Data Information from Secondary Sources
    Table 175. Key Data Information from Primary Sources
List of Figures
    Figure 1. Alpha L-Iduronidase Product Picture
    Figure 3. Global Alpha L-Iduronidase Market Share by Type in 2021 & 2028
    Figure 3. IDUA Product Picture
    Figure 4. EC 3.2.1.76 Product Picture
    Figure 5. Global Alpha L-Iduronidase Market Share by Application in 2021 & 2028
    Figure 6. Oncology
    Figure 7. Dermatology
    Figure 8. Immunology
    Figure 9. Musculoskeletal Disorders
    Figure 10. Alpha L-Iduronidase Report Years Considered
    Figure 11. Global Alpha L-Iduronidase Sales 2017-2028 (K Units)
    Figure 12. Global Alpha L-Iduronidase Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 13. Global Alpha L-Iduronidase Revenue 2017-2028 (US$ Million)
    Figure 14. Global Alpha L-Iduronidase Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 15. Global Alpha L-Iduronidase Sales Market Share by Region (2017-2022)
    Figure 16. Global Alpha L-Iduronidase Sales Market Share by Region (2023-2028)
    Figure 17. North America Alpha L-Iduronidase Sales YoY (2017-2028) & (K Units)
    Figure 18. North America Alpha L-Iduronidase Revenue YoY (2017-2028) & (US$ Million)
    Figure 19. Europe Alpha L-Iduronidase Sales YoY (2017-2028) & (K Units)
    Figure 20. Europe Alpha L-Iduronidase Revenue YoY (2017-2028) & (US$ Million)
    Figure 21. Asia-Pacific Alpha L-Iduronidase Sales YoY (2017-2028) & (K Units)
    Figure 22. Asia-Pacific Alpha L-Iduronidase Revenue YoY (2017-2028) & (US$ Million)
    Figure 23. Latin America Alpha L-Iduronidase Sales YoY (2017-2028) & (K Units)
    Figure 24. Latin America Alpha L-Iduronidase Revenue YoY (2017-2028) & (US$ Million)
    Figure 25. Middle East & Africa Alpha L-Iduronidase Sales YoY (2017-2028) & (K Units)
    Figure 26. Middle East & Africa Alpha L-Iduronidase Revenue YoY (2017-2028) & (US$ Million)
    Figure 27. The Alpha L-Iduronidase Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 28. The Top 5 and 10 Largest Manufacturers of Alpha L-Iduronidase in the World: Market Share by Alpha L-Iduronidase Revenue in 2021
    Figure 29. Global Alpha L-Iduronidase Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 30. Global Alpha L-Iduronidase Sales Market Share by Type (2017-2028)
    Figure 31. Global Alpha L-Iduronidase Revenue Market Share by Type (2017-2028)
    Figure 32. Global Alpha L-Iduronidase Sales Market Share by Application (2017-2028)
    Figure 33. Global Alpha L-Iduronidase Revenue Market Share by Application (2017-2028)
    Figure 34. North America Alpha L-Iduronidase Sales Market Share by Type (2017-2028)
    Figure 35. North America Alpha L-Iduronidase Revenue Market Share by Type (2017-2028)
    Figure 36. North America Alpha L-Iduronidase Sales Market Share by Application (2017-2028)
    Figure 37. North America Alpha L-Iduronidase Revenue Market Share by Application (2017-2028)
    Figure 38. North America Alpha L-Iduronidase Sales Share by Country (2017-2028)
    Figure 39. North America Alpha L-Iduronidase Revenue Share by Country (2017-2028)
    Figure 40. United States Alpha L-Iduronidase Revenue (2017-2028) & (US$ Million)
    Figure 41. Canada Alpha L-Iduronidase Revenue (2017-2028) & (US$ Million)
    Figure 42. Europe Alpha L-Iduronidase Sales Market Share by Type (2017-2028)
    Figure 43. Europe Alpha L-Iduronidase Revenue Market Share by Type (2017-2028)
    Figure 44. Europe Alpha L-Iduronidase Sales Market Share by Application (2017-2028)
    Figure 45. Europe Alpha L-Iduronidase Revenue Market Share by Application (2017-2028)
    Figure 46. Europe Alpha L-Iduronidase Sales Share by Country (2017-2028)
    Figure 47. Europe Alpha L-Iduronidase Revenue Share by Country (2017-2028)
    Figure 48. Germany Alpha L-Iduronidase Revenue (2017-2028) & (US$ Million)
    Figure 49. France Alpha L-Iduronidase Revenue (2017-2028) & (US$ Million)
    Figure 50. U.K. Alpha L-Iduronidase Revenue (2017-2028) & (US$ Million)
    Figure 51. Italy Alpha L-Iduronidase Revenue (2017-2028) & (US$ Million)
    Figure 52. Russia Alpha L-Iduronidase Revenue (2017-2028) & (US$ Million)
    Figure 53. Asia Pacific Alpha L-Iduronidase Sales Market Share by Type (2017-2028)
    Figure 54. Asia Pacific Alpha L-Iduronidase Revenue Market Share by Type (2017-2028)
    Figure 55. Asia Pacific Alpha L-Iduronidase Sales Market Share by Application (2017-2028)
    Figure 56. Asia Pacific Alpha L-Iduronidase Revenue Market Share by Application (2017-2028)
    Figure 57. Asia Pacific Alpha L-Iduronidase Sales Share by Region (2017-2028)
    Figure 58. Asia Pacific Alpha L-Iduronidase Revenue Share by Region (2017-2028)
    Figure 59. China Alpha L-Iduronidase Revenue (2017-2028) & (US$ Million)
    Figure 60. Japan Alpha L-Iduronidase Revenue (2017-2028) & (US$ Million)
    Figure 61. South Korea Alpha L-Iduronidase Revenue (2017-2028) & (US$ Million)
    Figure 62. India Alpha L-Iduronidase Revenue (2017-2028) & (US$ Million)
    Figure 63. Australia Alpha L-Iduronidase Revenue (2017-2028) & (US$ Million)
    Figure 64. China Taiwan Alpha L-Iduronidase Revenue (2017-2028) & (US$ Million)
    Figure 65. Indonesia Alpha L-Iduronidase Revenue (2017-2028) & (US$ Million)
    Figure 66. Thailand Alpha L-Iduronidase Revenue (2017-2028) & (US$ Million)
    Figure 67. Malaysia Alpha L-Iduronidase Revenue (2017-2028) & (US$ Million)
    Figure 68. Latin America Alpha L-Iduronidase Sales Market Share by Type (2017-2028)
    Figure 69. Latin America Alpha L-Iduronidase Revenue Market Share by Type (2017-2028)
    Figure 70. Latin America Alpha L-Iduronidase Sales Market Share by Application (2017-2028)
    Figure 71. Latin America Alpha L-Iduronidase Revenue Market Share by Application (2017-2028)
    Figure 72. Latin America Alpha L-Iduronidase Sales Share by Country (2017-2028)
    Figure 73. Latin America Alpha L-Iduronidase Revenue Share by Country (2017-2028)
    Figure 74. Mexico Alpha L-Iduronidase Revenue (2017-2028) & (US$ Million)
    Figure 75. Brazil Alpha L-Iduronidase Revenue (2017-2028) & (US$ Million)
    Figure 76. Argentina Alpha L-Iduronidase Revenue (2017-2028) & (US$ Million)
    Figure 77. Middle East and Africa Alpha L-Iduronidase Sales Market Share by Type (2017-2028)
    Figure 78. Middle East and Africa Alpha L-Iduronidase Revenue Market Share by Type (2017-2028)
    Figure 79. Middle East and Africa Alpha L-Iduronidase Sales Market Share by Application (2017-2028)
    Figure 80. Middle East and Africa Alpha L-Iduronidase Revenue Market Share by Application (2017-2028)
    Figure 81. Middle East and Africa Alpha L-Iduronidase Sales Share by Country (2017-2028)
    Figure 82. Middle East and Africa Alpha L-Iduronidase Revenue Share by Country (2017-2028)
    Figure 83. Turkey Alpha L-Iduronidase Revenue (2017-2028) & (US$ Million)
    Figure 84. Saudi Arabia Alpha L-Iduronidase Revenue (2017-2028) & (US$ Million)
    Figure 85. UAE Alpha L-Iduronidase Revenue (2017-2028) & (US$ Million)
    Figure 86. Alpha L-Iduronidase Value Chain
    Figure 87. Alpha L-Iduronidase Production Process
    Figure 88. Channels of Distribution
    Figure 89. Distributors Profiles
    Figure 90. Bottom-up and Top-down Approaches for This Report
    Figure 91. Data Triangulation
    Figure 92. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
ArmaGen Inc
BioStrategies LC
Denali Therapeutics Inc
EdiGene Inc
Gain Therapeutics Inc
Immusoft Corp
JCR Pharmaceuticals Co Ltd
Orchard Therapeutics Plc
Ossianix Inc
Rain Bio Inc
RegenxBio Inc
Tega Therapeutics Inc
Frequently Asked Questions
Alpha L-Iduronidase report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Alpha L-Iduronidase report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Alpha L-Iduronidase report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Exportin 1

Exportin 1 market is segmented by Type and by Application. Players, stakeholders, and other parti ... Read More